Skip to main content
. 2017 Oct-Dec;4(4):283–289. doi: 10.4103/2347-5625.212864

Table 1.

Univariate analysis of the association between the sociodemographic characteristics of respondents and their adherence to oral adjuvant endocrine therapy (n=157)

Sociodemographic characteristics n (%) Prevalence of high adherence (%)* P
Total study sample 157 (100.0) 40.8
Ethnic background
 Chinese 135 (86.0) 40.0 0.646
 Others 22 (14.0) 45.5
Age, years
 56 and younger 78 (49.7) 32.1 0.027
 57 and older 79 (50.3) 49.4
Marital status
 Married 116 (73.9) 41.4 0.792
 Single, divorced, or widowed 41 (26.1) 39.0
Number of children
 1 or more children 116 (73.9) 41.4 0.792
 None 41 (26.1) 39.0
Living arrangements
 Alone 13 (8.3) 15.4 0.075
 With family or someone else 144 (91.7) 43.1
Highest education level
 None, primary 49 (31.2) 42.9 0.853
 Secondary school 68 (43.3) 38.2
 Polytechnic, university and above 40 (25.5) 42.5
Employment status
 Employed 78 (49.7) 32.1 0.027
 Unemployed/retired 79 (50.3) 49.4
Type of payment
 Copay or third party pay 116 (73.9) 44.8 0.081
 Fully self-pay 41 (26.1) 29.3

Patients who scored 4 on MMAS-4 were considered to have high adherence, P value based on Chi-square test, Others refers to Malay, Indians, and others. MMAS-4: Morisky Medication Adherence Scale-4 items. Use of the ©MMAS™ is protected by US and International copyright and trademark laws. Permission for use is required. A license agreement is available from: Donald E. Morisky, MMAS Research) LLC 14725 NE 20th St. Bellevue WA 98007